The HLA DR/DQ gene analyses two important genomic markers called HLA-DQB1 and HLA-DR that can reveal important information relating to autoimmune disorders as well as inflammatory disorders. It is said that approximately 25% of the world’s population have one of the 10 susceptible types of HLA DR/DQ genes.
The HLA DR/DQ gene test shows haplotypes (gene combinations) which show susceptibility to mould, Lyme and conditions. The report contains a Rosetta Stone, developed by Dr. Ritchie Shoemaker which offers a summary of the various susceptible genetic types, with directions for interpretation.
